Skip to main navigation
Skip to search
Skip to main content
Research Profiles at Washington University School of Medicine Home
Help & FAQ
Departments, Divisions and Centers
Search by expertise, name or affiliation
Can We Exploit the Molecular Heterogeneity of Aggressive B Cell Lymphomas Into Effective New Therapies?
Daniel J. Landsburg,
Brad S. Kahl
Section of Medical Oncology
Siteman Cancer Center
Contribution to journal
Dive into the research topics of 'Can We Exploit the Molecular Heterogeneity of Aggressive B Cell Lymphomas Into Effective New Therapies?'. Together they form a unique fingerprint.